Fair Value Calculator Fair Value Calculator
EN DE

GRATEXI (GRATEXI) Fair Value & Analysis

IN · Market cap ₹79.2M

G GRATEXI GRATEXI · BSE
Price₹26.10
Fair Value₹7.26
Upside-72.2%
Quality69/100
Watch GRATEXI for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹5.45 – ₹9.08

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price +1.5% over the past month.

Price vs Fair Value (12 months)

₹26.13 ₹16.47 Fair Value ₹7.26 Jul 2025 Jul 2026

12‑month range ₹16.47 – ₹26.13 · fair‑value band ₹5.45 – ₹9.08 · the ₹26.10 price screens above the ₹7.26 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

GRATEXI (GRATEXI) currently trades at ₹26.10, while our model-based Fair Value estimate is ₹7.26 — implying the stock looks roughly 72.2% overvalued today. We read business quality at 69/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, GRATEXI generated revenue of ₹42.7M at a net margin of 2.6%. Revenue grew 81.5% year over year. It earns a return on equity of 3.0%. Net debt stands at ₹1.6M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹5.45 (bear case) to ₹9.08 (bull case); at ₹26.10, the current price sits above that range. The share trades about 1% below its 52-week high and 61% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹42.7M
Revenue growth (YoY) +81.5%
Net margin 2.6%
Return on equity 3.0%
Free cash flow −₹103B FY2026
P/E ratio 72.5
More key figures
Operating margin 5.5%
EPS (TTM) ₹0.3600
EPS growth (YoY) +265%
Net debt ₹1.6M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

GRATEXI reported revenue of ₹42.7M in FY2026 versus ₹21.1M in FY2022, a compound +19.3%/yr. Reported net income was ₹1.1M in FY2026, compounding +2.7%/yr from FY2022.

Revenue +19.3%/yr
FY22 ₹21.1M
FY23 ₹30.7M
FY24 ₹28.3M
FY25 ₹37.5M
FY26 ₹42.7M
Net income +2.7%/yr
FY22 ₹991K
FY23 ₹1.9M
FY24 ₹940K
FY25 ₹714K
FY26 ₹1.1M

Is GRATEXI fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "GRATEXI Fair Value". https://www.fairvalue-calculator.com/stock/GRATEXI

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is GRATEXI (GRATEXI) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹7.26 versus a price of ₹26.10 — about −72% (overvalued). Model-based estimate, not financial advice.
What is the fair value of GRATEXI?
Our model-based fair value for GRATEXI is ₹7.26 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹26.10.
What is the quality score of GRATEXI?
GRATEXI has a Quality Score of 69/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of GRATEXI (GRATEXI)?
GRATEXI reported trailing-twelve-month revenue of about ₹42.7M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of GRATEXI?
The net profit margin of GRATEXI is about 2.6%, meaning it keeps roughly 2.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.